Alex Colville

General Partner age1

Seminars

Thursday 29th January 2026
Investing in Geroscience: A New Frontier in Biotech Capital for Longevity Innovation
2:00 pm
  • Exploring investor appetite for longevity-focused startups and clinical programs
  • Defining inflection points from IND filing to proof-of-mechanism readouts to guide investment timing
  • Highlighting de-risking strategies through biomarkers, partnerships, and AI platforms to improve predictability
Alex Colville, speaking at 6th Age-Related Disease Therapeutics Summit